세계의 내시경 진단 및 치료 기기 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Endoscopic Diagnostic and Therapeutic Device was estimated to be worth US$ 7269 million in 2024 and is forecast to a readjusted size of US$ 11089 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Endoscopic Diagnostic and Therapeutic Device cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Endoscopic diagnostic and therapeutic devices are specialized medical instruments designed to be used with endoscopes for the visualization, diagnosis, and treatment of conditions within the body's internal cavities or luminal organs. These devices can include biopsy forceps, snares, injection needles, electrosurgical tools, and other accessories that enable minimally invasive procedures, allowing for tissue sampling, polyp removal, bleeding control, and lesion treatment with reduced patient trauma and faster recovery times.In 2024, global Endoscopic diagnostic and therapeutic devices production reached approximately 550 m units, with an average global market price of around US$ 13.22 perunit.

Population aging and rising GI/respiratory disease burdens, together with government-backed early screening and minimally invasive care, are shifting endoscopy from "diagnostics only" to "diagnostics-to-therapy." Company annual reports and broker coverage indicate HD/NBI imaging, single-use scopes/consumables, and integrated energy platforms are lifting procedure throughput and bed turnover. Reimbursement expansion and volume-based procurement are catalyzing structural growth and penetration into lower-tier hospitals. Meanwhile, AI quality control and CADx/CADe improve early-cancer detection, and hospitals-via discipline building and day-surgery expansion-treat endoscopic therapy as a high-throughput, cost-effective growth engine.

Tighter regulation, higher standards, and rising compliance costs persist. Although localization of key components (sensors, optics, power/energy control) is progressing, consistency and clinical-evidence depth still require time. Single-use adoption heightens cost sensitivity; without aligned reimbursement and pricing mechanisms, margins can be compressed. Global supply chains face raw-material and logistics volatility, while overseas market access, registration timelines, and academic promotion needs elevate launch uncertainty and lengthen cash cycles.

Clinical demand is moving from "see" to "see clearly, treat effectively, and streamline." Hospitals prefer end-to-end solutions-imaging, access, energy, and traceable SPD services-with day-surgery pathways driving share gains for single-use and easy-reprocessing products. Advanced procedures (ESD/POEM/ERCP/EMR/bronchial interventions) are scaling, pulling through high-end energy systems and interventional disposables; primary care favors durable, easy-to-maintain devices and standardized kits. Internationally, "premium + localized service" coexists with value-oriented demand in emerging markets, shaping multi-tier, scenario-based procurement logic.

This report aims to provide a comprehensive presentation of the global market for Endoscopic Diagnostic and Therapeutic Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Endoscopic Diagnostic and Therapeutic Device by region & country, by Type, and by Application.

The Endoscopic Diagnostic and Therapeutic Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endoscopic Diagnostic and Therapeutic Device.

Market Segmentation

By Company

• Olympus
• Boston Scientific
• Cook Medical
• Micro Tech
• CONMED
• Always Good Solutions
• KARL STORZ
• HOYA
• Anrei Medical
• Jiangsu Weidekang
• Changzhou Jiuhong
• Sonoscape
• Aohua Medical

Segment by Type

• Biopsy
• Hemostasis and Closure
• Dilation
• EUS
• EMR/ESD
• ERCP

Segment by Application

• Gastroenterology
• Respiratory
• Other

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Endoscopic Diagnostic and Therapeutic Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Endoscopic Diagnostic and Therapeutic Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Endoscopic Diagnostic and Therapeutic Device in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Endoscopic Diagnostic and Therapeutic Device Product Introduction
• 1.2 Global Endoscopic Diagnostic and Therapeutic Device Market Size Forecast
  • 1.2.1 Global Endoscopic Diagnostic and Therapeutic Device Sales Value (2020-2031)
  • 1.2.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume (2020-2031)
  • 1.2.3 Global Endoscopic Diagnostic and Therapeutic Device Sales Price (2020-2031)
• 1.3 Endoscopic Diagnostic and Therapeutic Device Market Trends & Drivers
  • 1.3.1 Endoscopic Diagnostic and Therapeutic Device Industry Trends
  • 1.3.2 Endoscopic Diagnostic and Therapeutic Device Market Drivers & Opportunity
  • 1.3.3 Endoscopic Diagnostic and Therapeutic Device Market Challenges
  • 1.3.4 Endoscopic Diagnostic and Therapeutic Device Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Endoscopic Diagnostic and Therapeutic Device Players Revenue Ranking (2024)
• 2.2 Global Endoscopic Diagnostic and Therapeutic Device Revenue by Company (2020-2025)
• 2.3 Global Endoscopic Diagnostic and Therapeutic Device Players Sales Volume Ranking (2024)
• 2.4 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Company Players (2020-2025)
• 2.5 Global Endoscopic Diagnostic and Therapeutic Device Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Endoscopic Diagnostic and Therapeutic Device Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Endoscopic Diagnostic and Therapeutic Device Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Endoscopic Diagnostic and Therapeutic Device
• 2.9 Endoscopic Diagnostic and Therapeutic Device Market Competitive Analysis
  • 2.9.1 Endoscopic Diagnostic and Therapeutic Device Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Endoscopic Diagnostic and Therapeutic Device Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endoscopic Diagnostic and Therapeutic Device as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Biopsy
  • 3.1.2 Hemostasis and Closure
  • 3.1.3 Dilation
  • 3.1.4 EUS
  • 3.1.5 EMR/ESD
  • 3.1.6 ERCP
• 3.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Value by Type
  • 3.2.1 Global Endoscopic Diagnostic and Therapeutic Device Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Value, by Type (2020-2031)
  • 3.2.3 Global Endoscopic Diagnostic and Therapeutic Device Sales Value, by Type (%) (2020-2031)
• 3.3 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Type
  • 3.3.1 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Endoscopic Diagnostic and Therapeutic Device Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Gastroenterology
  • 4.1.2 Respiratory
  • 4.1.3 Other
• 4.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Value by Application
  • 4.2.1 Global Endoscopic Diagnostic and Therapeutic Device Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Value, by Application (2020-2031)
  • 4.2.3 Global Endoscopic Diagnostic and Therapeutic Device Sales Value, by Application (%) (2020-2031)
• 4.3 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Application
  • 4.3.1 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Endoscopic Diagnostic and Therapeutic Device Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Endoscopic Diagnostic and Therapeutic Device Sales Value by Region
  • 5.1.1 Global Endoscopic Diagnostic and Therapeutic Device Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Value by Region (2020-2025)
  • 5.1.3 Global Endoscopic Diagnostic and Therapeutic Device Sales Value by Region (2026-2031)
  • 5.1.4 Global Endoscopic Diagnostic and Therapeutic Device Sales Value by Region (%), (2020-2031)
• 5.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Region
  • 5.2.1 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Region (2020-2025)
  • 5.2.3 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Region (2026-2031)
  • 5.2.4 Global Endoscopic Diagnostic and Therapeutic Device Sales Volume by Region (%), (2020-2031)
• 5.3 Global Endoscopic Diagnostic and Therapeutic Device Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 5.4.2 North America Endoscopic Diagnostic and Therapeutic Device Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 5.5.2 Europe Endoscopic Diagnostic and Therapeutic Device Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Endoscopic Diagnostic and Therapeutic Device Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 5.7.2 South America Endoscopic Diagnostic and Therapeutic Device Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Endoscopic Diagnostic and Therapeutic Device Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Endoscopic Diagnostic and Therapeutic Device Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Endoscopic Diagnostic and Therapeutic Device Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Endoscopic Diagnostic and Therapeutic Device Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 6.3.2 United States Endoscopic Diagnostic and Therapeutic Device Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Endoscopic Diagnostic and Therapeutic Device Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 6.4.2 Europe Endoscopic Diagnostic and Therapeutic Device Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Endoscopic Diagnostic and Therapeutic Device Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 6.5.2 China Endoscopic Diagnostic and Therapeutic Device Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Endoscopic Diagnostic and Therapeutic Device Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 6.6.2 Japan Endoscopic Diagnostic and Therapeutic Device Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Endoscopic Diagnostic and Therapeutic Device Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 6.7.2 South Korea Endoscopic Diagnostic and Therapeutic Device Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Endoscopic Diagnostic and Therapeutic Device Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Endoscopic Diagnostic and Therapeutic Device Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Endoscopic Diagnostic and Therapeutic Device Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Endoscopic Diagnostic and Therapeutic Device Sales Value, 2020-2031
  • 6.9.2 India Endoscopic Diagnostic and Therapeutic Device Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Endoscopic Diagnostic and Therapeutic Device Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Olympus
  • 7.1.1 Olympus Company Information
  • 7.1.2 Olympus Introduction and Business Overview
  • 7.1.3 Olympus Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Olympus Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.1.5 Olympus Recent Development
• 7.2 Boston Scientific
  • 7.2.1 Boston Scientific Company Information
  • 7.2.2 Boston Scientific Introduction and Business Overview
  • 7.2.3 Boston Scientific Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Boston Scientific Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.2.5 Boston Scientific Recent Development
• 7.3 Cook Medical
  • 7.3.1 Cook Medical Company Information
  • 7.3.2 Cook Medical Introduction and Business Overview
  • 7.3.3 Cook Medical Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Cook Medical Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.3.5 Cook Medical Recent Development
• 7.4 Micro Tech
  • 7.4.1 Micro Tech Company Information
  • 7.4.2 Micro Tech Introduction and Business Overview
  • 7.4.3 Micro Tech Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Micro Tech Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.4.5 Micro Tech Recent Development
• 7.5 CONMED
  • 7.5.1 CONMED Company Information
  • 7.5.2 CONMED Introduction and Business Overview
  • 7.5.3 CONMED Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 CONMED Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.5.5 CONMED Recent Development
• 7.6 Always Good Solutions
  • 7.6.1 Always Good Solutions Company Information
  • 7.6.2 Always Good Solutions Introduction and Business Overview
  • 7.6.3 Always Good Solutions Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Always Good Solutions Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.6.5 Always Good Solutions Recent Development
• 7.7 KARL STORZ
  • 7.7.1 KARL STORZ Company Information
  • 7.7.2 KARL STORZ Introduction and Business Overview
  • 7.7.3 KARL STORZ Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 KARL STORZ Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.7.5 KARL STORZ Recent Development
• 7.8 HOYA
  • 7.8.1 HOYA Company Information
  • 7.8.2 HOYA Introduction and Business Overview
  • 7.8.3 HOYA Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 HOYA Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.8.5 HOYA Recent Development
• 7.9 Anrei Medical
  • 7.9.1 Anrei Medical Company Information
  • 7.9.2 Anrei Medical Introduction and Business Overview
  • 7.9.3 Anrei Medical Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Anrei Medical Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.9.5 Anrei Medical Recent Development
• 7.10 Jiangsu Weidekang
  • 7.10.1 Jiangsu Weidekang Company Information
  • 7.10.2 Jiangsu Weidekang Introduction and Business Overview
  • 7.10.3 Jiangsu Weidekang Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Jiangsu Weidekang Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.10.5 Jiangsu Weidekang Recent Development
• 7.11 Changzhou Jiuhong
  • 7.11.1 Changzhou Jiuhong Company Information
  • 7.11.2 Changzhou Jiuhong Introduction and Business Overview
  • 7.11.3 Changzhou Jiuhong Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Changzhou Jiuhong Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.11.5 Changzhou Jiuhong Recent Development
• 7.12 Sonoscape
  • 7.12.1 Sonoscape Company Information
  • 7.12.2 Sonoscape Introduction and Business Overview
  • 7.12.3 Sonoscape Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Sonoscape Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.12.5 Sonoscape Recent Development
• 7.13 Aohua Medical
  • 7.13.1 Aohua Medical Company Information
  • 7.13.2 Aohua Medical Introduction and Business Overview
  • 7.13.3 Aohua Medical Endoscopic Diagnostic and Therapeutic Device Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Aohua Medical Endoscopic Diagnostic and Therapeutic Device Product Offerings
  • 7.13.5 Aohua Medical Recent Development

8 Industry Chain Analysis

• 8.1 Endoscopic Diagnostic and Therapeutic Device Industrial Chain
• 8.2 Endoscopic Diagnostic and Therapeutic Device Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Endoscopic Diagnostic and Therapeutic Device Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Endoscopic Diagnostic and Therapeutic Device Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer